Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • Eating Well (or at Least Not terribly) at Fast Food Resturants
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Type 2 Issues Articles

Looking for Mr. Good Pain
Ready for a Diabetes Drug Tune-Up?
Diabetes Is Certainly a Journey.
You’ve Just Been Diagnosed With Type 2: Five Things to Keep in Mind
Two New Promising Type 2 Drugs in the Pipeline
At the Crossroads, I Choose Insulin
Altering Gut Bacteria Could Rival Bypass Surgery Effects
Is it dangerous to continually have low-grade ketone levels in your blood?
What meds do you recommend to control elevated cholesterol?
Insulin Linked to Type 2 Weight Gains
Type 2 Issues Archives
Browse the Type 2 Issues Archives
Subscribe to the Community RSS Feed
Print | Email | Share | Comments (0)

Tracking Cardiovascular Health in Type 2s


Mar 1, 2005

Investigating Ways to Measure the Benefits of Statins

Two years of statin therapy showed no effect on carotid intima-media thickness (IMT) in people with type 2 diabetes without apparent cardiovascular disease. However, there was a significantly lower cardiovascular event rate, according to researchers in the Netherlands.

A total of 250 patients with type 2 were given either a statin drug or placebo daily for two years. There was no significant change of carotid IMT over the two years in either group, but LDL cholesterol was lowered by 25 percent in the statin group and increased by 8 percent in the placebo group.

Cardiovascular events occurred in 12 patients in the placebo group and in two patients in the statin group.

Since there was no significant change in IMT, the researchers say that other methods should be used for identifying cardiovascular disease in type 2s.

—Diabetes Care, December 2004

Clinical adviser’s note: Initially, patients in the treatment group of this randomized study were given cerivastatin (U.S. brand name Baycol) 0.4 mg per day. When this drug was withdrawn from the market, the treatment was changed to Zocor (simvastatin) 20 mg per day without unblinding the study.

For more information on why the lipid-regulating drugs called statins are recommended for most people with diabetes, especially those over age 40 even if cholesterol levels are normal, see Dr. Einhorn’s article on page 18 of our November 2004 issue.

Categories: Diabetes, Diabetes, Heart Care & Heart Disease, Type 2 Issues

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Mar 1, 2005

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.